Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Rituximab Cll'

Rituximab Cll published presentations and documents on DocSlides.

Chronic lymphocytic leukemia,

Chronic lymphocytic leukemia,

  • natalia-silvester
  • 31 Slides

New agents timing?. Agne Paner, MD. Assistant pro...

Integration of Novel Therapies in WM and CLL : When and How

Integration of Novel Therapies in WM and CLL : When and How

  • giovanna-bartolotta
  • 55 Slides

Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

  • conchita-marotz
  • 0 Slides

ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....

Carfilzomib , Rituximab and Dexamethasone (

Carfilzomib , Rituximab and Dexamethasone (

  • mindeeli
  • 10 Slides

CaRD. ) Is Highly . Active and . Offers a Neuropat...

Patients with total IgG <400 mg/dL while receiving rituximab should

Patients with total IgG <400 mg/dL while receiving rituximab should

  • ivy
  • 35 Slides

NOT. receive IgG replacement therapy. . AAIFNC F...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

  • luanne-stotts
  • 66 Slides

Moderator. Neil Love, MD. Mollie Moran, MSN, CNP,...

A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K

A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K

  • windbey
  • 10 Slides

δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...

Module 3: Chronic Lymphocytic Leukemia

Module 3: Chronic Lymphocytic Leukemia

  • CottonTails
  • 26 Slides

Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...

Clonal Evolution in CLL:

Clonal Evolution in CLL:

  • karlyn-bohler
  • 53 Slides

Impact . on t. iming . of . therapy. Nicholas Chi...

CLL Stromal cell protect

CLL Stromal cell protect

  • tawny-fly
  • 20 Slides

CLL Stromal cell protect Conventional therapies V...

Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269

Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269

  • carny
  • 23 Slides

Mallaig. Sprinkling Song . Spirit of God, come dw...

Update on chronic lymphocytic leukemia (CLL) treatment

Update on chronic lymphocytic leukemia (CLL) treatment

  • joy
  • 91 Slides

Dr Mona Yuklea. Hematology Department, Meir Hospi...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

  • alexa-scheidler
  • 259 Slides

Contemporary Treatment Strategies and Optimal Seq...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

  • tatiana-dople
  • 254 Slides

Contemporary Treatment Strategies and Optimal Seq...

A Closer Look at Pemphigus Vulgaris: Clinical Challenges and

A Closer Look at Pemphigus Vulgaris: Clinical Challenges and

  • celsa-spraggs
  • 0 Slides

Emerging Treatments . Description of Program. Thi...

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI)

  • ellena-manuel
  • 0 Slides

Swiss Group for Clinical Cancer Research (SAKK). ...

Indolent Non-Hodgkin L

Indolent Non-Hodgkin L

  • danika-pritchard
  • 0 Slides

ymphoma. Sobia Ozair. March 8, 2017. MD Anderson ...

Updates in Lymphoma From Recent Congresses

Updates in Lymphoma From Recent Congresses

  • lindy-dunigan
  • 0 Slides

Therapeutic Targets in CLL. Venetoclax in Patient...

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

  • mitsue-stanley
  • 25 Slides

Bertrand Coiffier. Service d. ’. Hématologie. ...

Published in nejm in sep 2016

Published in nejm in sep 2016

  • Wildboyz
  • 24 Slides

RITUXIMAB IN B-LINEAGE ADULT ACUTE LYMPHOBLASTIC L...

rials as treatment options for eligible patients

rials as treatment options for eligible patients

  • elysha
  • 13 Slides

Page 1 of 13 Note : Consider C linical T . Wa...

227 EMEA 2005 Since all the treatment regimens used so far have only

227 EMEA 2005 Since all the treatment regimens used so far have only

  • priscilla
  • 27 Slides

Zevalin, supplied as kit for radiopharmaceutical p...

Case 2012-09

Case 2012-09

  • tawny-fly
  • 34 Slides

Diagnostic Slide Session. AANP - Annual Meeting. ...

Implementing Best Practices in Chronic Lymphocytic Leukemia

Implementing Best Practices in Chronic Lymphocytic Leukemia

  • myesha-ticknor
  • 44 Slides

CLL/SLL. Use of Markers in Nonclinical Trial Prac...

Case Study Interpretation

Case Study Interpretation

  • lindy-dunigan
  • 29 Slides

Spring 2010. Clinical history. A 62 year old man ...

chronic lymphocytic leukemia

chronic lymphocytic leukemia

  • test
  • 52 Slides

is the most common type of . leukemia. . . CLL in...

Mechanisms of

Mechanisms of

  • giovanna-bartolotta
  • 42 Slides

Ibrutinib. Sensitivity and Resistance in CLL. Y....

Personalized Therapy in Relapsed or Refractory CLL

Personalized Therapy in Relapsed or Refractory CLL

  • kittie-lecroy
  • 0 Slides

IWCLL Criteria for Treating CLL. Other Considerat...

Making Sense of Novel Prognostics: NOTCH1, SF3B1

Making Sense of Novel Prognostics: NOTCH1, SF3B1

  • olivia-moreira
  • 0 Slides

Jennifer R Brown, MD PhD. Director, CLL Center. D...

Interesting case conference

Interesting case conference

  • natalia-silvester
  • 0 Slides

Mary-Margaret Allen, MD. February 24, 2015. 58 . ...

Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP

Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP

  • ellena-manuel
  • 25 Slides

Pharmacist Focus on BTK Inhibitors Moderator Shil...

Curriculum Guide 2012 French I

Curriculum Guide 2012 French I

  • audrey
  • 13 Slides

Unit Objectives Approx 15 week per unit New Essent...

www.society -for- hematopathology.org

www.society -for- hematopathology.org

  • yvonne
  • 13 Slides

SH2021-XX . Marrow involvement by clonally-related...

C hronic lymphocytic

C hronic lymphocytic

  • della
  • 17 Slides

leukemia. Magdalena Olszewska-Szopa. Definition. C...

Using DNA copy number aberrations to

Using DNA copy number aberrations to

  • pamela
  • 23 Slides

identify candidate drivers of . carcinogenesis in ...

CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES

CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES

  • susan
  • 34 Slides

Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...

Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran

Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran

  • Tigerwoods
  • 27 Slides

Mehrdad. . Payandeh. Department of Hematology and...

Comparison between Time-

Comparison between Time-

  • LifeOfTheParty
  • 10 Slides

Limited,Venetoclax. -Based and Continuous Bruton ....

Presenter : CR 周益聖

Presenter : CR 周益聖

  • CottonTails
  • 36 Slides

Supervisor: VS . 曾主任. Cell 152, 714–726, F...

PATIENT EDUCATION

PATIENT EDUCATION

  • brooke
  • 10 Slides

Introduction Chronic lymphocytic leukemia (CLL) is...

Copyright © 2024 DocSlides. All Rights Reserved